GC Pharm cruising to commercialize flu vaccine for the elderly

Published: 2018-08-03 16:29:00
Updated: 2018-08-06 09:32:46

GC Pharm has gotten a step closer to commercializing influenza vaccines that are more effective with the elderly.

GC Pharm(CEO Eun-Cheol Huh) announced on the 26th that they acquired approval of Phase II clinical trial for its high-volume quadrivalent influenza vaccine ‘GC3114’ from the Ministry...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.